Complications of cirrhosis III. Hepatic encephalopathy
- 1 January 2000
- journal article
- review article
- Published by Elsevier in Journal of Hepatology
- Vol. 32, 171-180
- https://doi.org/10.1016/s0168-8278(00)80424-9
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Evaluation of the efficacy and safety of flumazenil in the treatment of portal systemic encephalopathy: a double blind, randomised, placebo controlled multicentre study.Gut, 1996
- Astrocytic-Ammonia Interactions in Hepatic EncephalopathySeminars in Liver Disease, 1996
- Noninvasive Neuroinvestigation in Liver DiseaseSeminars in Liver Disease, 1996
- Pallidal lesions in patients with liver cirrhosis: clinical and MRI evaluationMetabolic Brain Disease, 1995
- Regional alterations of dopamine and its metabolites in rat brain following portacaval anastomosisNeurochemical Research, 1995
- Increased cerebrospinal fluid lactate reflects deterioration of neurological status in experimental portal-systemic encephalopathyMetabolic Brain Disease, 1991
- Altered Cerebral Blood Flow and Glucose Metabolism in Patients with Liver Disease and Minimal EncephalopathyJournal of Cerebral Blood Flow & Metabolism, 1991
- Minimum protein requirements in liver cirrhosis determined by nitrogen balance measurements at three levels of protein intakeClinical Nutrition, 1989
- Ammonia: Key factor in the pathogenesis of hepatic encephalopathyNeurochemical Pathology, 1987
- CNS tryptamine metabolism in hepatic comaJournal Of Neural Transmission-Parkinsons Disease and Dementia Section, 1980